Maria Ekholm

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2026
Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors.

Nicole L Brown, Sacha J Howell, Dimitrios Papantoniou

|Dec 18, 2024
Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.

Pia Mouhanna, Anders Ståhlberg, Daniel Andersson

|May 04, 2024
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study.

Kian Chin, Amalia H Landén, Anikó Kovács

|Jun 10, 2022
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study.

Una Kjällquist, Balazs Acs, Sara Margolin

|Nov 29, 2021
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer.

Faye Coe, Vivek Misra, Yamini McCabe

|Dec 28, 2020
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.

Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm

Pageof 2

Frequent Collaborators

2 joint publications

Christine Lundgren

1 joint publications

Pär-Ola Bendahl

1 joint publications

Mårten Fernö

1 joint publications

Carina Forsare